India is home to over 100 million people with diabetes and approximately 250 million classified as obese or overweight.[15] What makes the situation uniquely dangerous is the Thin-Fat Indian paradox: South Asians tend to accumulate more visceral (belly) fat, liver fat, and less lean muscle mass at lower body weights than Western populations.[8][9][10] While GLP-1 medications are a global phenomenon, they are particularly critical for the Thin-Fat Indian phenotype
C18 fatty diacid conjugation integrity verification and Aib8 substitution confirmation by mass spectrometry are critical specifications beyond standard HPLC purity
The triple-agonist mechanism (GLP-1 + GIP + glucagon) produces higher GI rates than semaglutide or tirzepatide alone, with the glucagon receptor being the primary driver of the difference
Why is the molecule modified rather than using natural GLP-1
Blood glucose monitoring is important, especially for those with diabetes or insulin resistance
When your body doesnt have enough of it, you may feel tired, weak, and even struggle with memory or concentration